U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 7 of 7 results

Status:
US Previously Marketed
First approved in 1994

Class (Stereo):
CHEMICAL (ABSOLUTE)



Spirapril (Renormax) is an ACE inhibitor antihypertensive drug used to treat hypertension. Spiraprilat, the active metabolite of spirapril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angio...
Status:
Possibly Marketed Outside US
First approved in 1987

Class (Stereo):
CHEMICAL (ACHIRAL)


Mebrofenin is a chelating component which, when attached to Technetium TC-99M, forms a diagnostic drug marketed under the name Choletec. Choletec is approved by FDA as a hepatobiliary imaging agent.
mixture
Status:
Possibly Marketed Outside US

Class:
MIXTURE


Halquinols (halquinol) is an antimicrobial for treatment of skin infections available as topical skin pharmaceutical. Tarquinor skin cream, a dermatological preparation of halquinol 0.2% and 1% coal tar has been approved for use in New Zealand in 196...
Status:
US Previously Marketed
First approved in 1994

Class (Stereo):
CHEMICAL (ABSOLUTE)



Spirapril (Renormax) is an ACE inhibitor antihypertensive drug used to treat hypertension. Spiraprilat, the active metabolite of spirapril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angio...
Status:
US Previously Marketed
First approved in 1994

Class (Stereo):
CHEMICAL (ABSOLUTE)



Spirapril (Renormax) is an ACE inhibitor antihypertensive drug used to treat hypertension. Spiraprilat, the active metabolite of spirapril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angio...
Status:
US Previously Marketed
First approved in 1994

Class (Stereo):
CHEMICAL (ABSOLUTE)



Spirapril (Renormax) is an ACE inhibitor antihypertensive drug used to treat hypertension. Spiraprilat, the active metabolite of spirapril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angio...
Status:
Possibly Marketed Outside US
First approved in 1987

Class (Stereo):
CHEMICAL (ACHIRAL)


Mebrofenin is a chelating component which, when attached to Technetium TC-99M, forms a diagnostic drug marketed under the name Choletec. Choletec is approved by FDA as a hepatobiliary imaging agent.